Expanding the Treatment Toolbox for Platinum-Resistant Ovarian Cancer
The landscape for platinum-resistant ovarian cancer (PROC) is evolving, offering new hope through targeted therapies, immunotherapy and clinical research.
Oncology News
-
-
Moving Toward Precision Medicine for HPV+ Oropharyngeal Cancers
Improved molecular diagnostics represents the next frontier in head and neck oncology.
-
Moving Beyond Lifetime Risk to Personalized Breast Cancer Screening
Dr. Lauren Cornell examines how clinicians can shift toward shorter-term, risk-based strategies for breast cancer screening.
-
MRI-Guided Ultrasound Ablation Offers a Middle Ground in Prostate Cancer Care
Deferring prostate cancer treatment can help preserve urinary and sexual functions but introduces the psychological burden of living with a known cancer.
-
Tibial Neuromodulation and the Shift in Treatment Landscape for Urge Urinary Incontinence
A minimally invasive implantable tibial neuromodulation (ITNM) therapy, Altaviva is a new treatment available at AdventHealth for urinary incontinence.
-
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
-
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
-
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was... -
Forging New Frontiers in Telesurgery to Improve Global Health Access, Outcomes and Equity
In our latest Clinician’s View, Dr. Patel shares his team’s journey toward improving global health access, outcomes and equity through telesurgery, including how they are ensuring the safety, quality...
-
Surgical Resection of Rare Pediatric Desmoid Jaw Tumor Optimizes Outcome and Helps Patient Avoid Chemotherapy
In our latest clinician’s view, Dr. Lopez shares how he, along with a multidisciplinary clinical team, were able to plan for this complex case and completely remove the tumor surgically, allowing...
-
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
-
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
-
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...